Oragenics (OGEN) SEC Filings & 10K Form

$1.03
-0.03 (-2.83%)
(As of 04/26/2024 ET)

Recent Oragenics SEC Filings

DateFilerForm TypeView
04/15/2024
7:01 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:16 PM
Oragenics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
6:38 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:24 PM
Lind Global Fund II LP (Filed by)
Oragenics (Subject)
Form SC 13G
03/01/2024
3:05 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
8:03 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
7:06 PM
Odyssey Health, Inc. (Filed by)
Oragenics (Subject)
Form SC 13D
02/07/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
4:18 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
4:30 PM
KOSKI ROBERT C (Reporting)
Oragenics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/16/2024
8:04 AM
Oragenics (Filer)
Form 424B5
01/16/2024
8:08 AM
Oragenics (Subject)
Form FWP
01/16/2024
8:10 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
3:37 PM
Oragenics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/02/2024
3:40 PM
Oragenics (Issuer)
REDMOND J MICHAEL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
8:22 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
6:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
2:45 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
4:23 PM
Oragenics (Issuer)
Telling Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
4:50 PM
Oragenics (Subject)
Telling Fred (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
2:45 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
1:37 PM
Oragenics (Filer)
Form DEFA14A
11/02/2023
6:00 AM
Oragenics (Filer)
Form DEFA14A
11/02/2023
6:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
3:30 PM
Oragenics (Filer)
Form DEFA14A
10/06/2023
3:25 PM
Cassidy Bruce A. Sr. (Reporting)
Oragenics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/06/2023
3:28 PM
GANDOLFO JOHN P (Reporting)
Oragenics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/06/2023
3:31 PM
Cassidy Bruce A. Sr. (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:33 PM
GANDOLFO JOHN P (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
4:29 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
5:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
3:15 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:09 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:OGEN) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners